What is the diagnostic approach for dementia, including tests to order and methods to detect malingering?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Dementia: A Comprehensive Approach

The diagnosis of dementia requires a multidimensional assessment including standardized cognitive testing, informant reports, laboratory testing, and neuroimaging, with neuropsychological evaluation recommended for complex or atypical presentations. 1

Diagnostic Criteria

  • Cognitive or behavioral symptoms must interfere with ability to function at work or usual activities, represent a decline from previous levels of functioning, and not be explained by delirium or major psychiatric disorder 2
  • Diagnosis should be based on history from both patient and knowledgeable informant, plus objective cognitive assessment 2, 1
  • Key cognitive domains affected include memory, reasoning, visuospatial abilities, language function, and changes in personality or behavior 2

Initial Assessment

  • Obtain corroborative history from a reliable informant, which is essential for diagnostic accuracy 1
  • Use standardized cognitive assessment tools:
    • Montreal Cognitive Assessment (MoCA) - more sensitive for mild cognitive impairment 2, 1
    • Mini-Mental State Examination (MMSE) - high sensitivity for moderate dementia 2, 3
    • Clock Drawing Test - useful supplementary test 1
  • Assess functional status using informant-based tools:
    • Everyday Cognition (ECog) - measures informant's report of cognitive changes 1
    • AD8, IQCODE, or Quick Dementia Rating System (QDRS) - measure informant's report on cognitive and functional changes 1
    • Functional Assessment Questionnaire (FAQ) or Lawton-Brody IADL - measure functional changes 1
    • Neuropsychiatric Inventory Questionnaire (NPI-Q) or Mild Behavioral Impairment Checklist (MBI-C) - measure behavioral changes 1

Laboratory Testing (Tier 1)

  • Complete blood count 4, 5
  • Comprehensive metabolic panel including:
    • Electrolytes (sodium, potassium) 4, 5
    • Glucose 4, 5
    • Calcium 4, 6
    • Renal function (BUN, creatinine) 4, 5
    • Liver function tests 4, 7
  • Thyroid function tests (TSH) 4, 5
  • Vitamin B12 levels 4, 6

Neuroimaging (Tier 1)

  • Non-contrast brain MRI (preferred) or CT scan if MRI is unavailable 4, 1
  • Neuroimaging helps evaluate:
    • Patterns of atrophy (hippocampal and cortical) 4, 7
    • Vascular lesions such as infarcts 4, 8
    • Non-degenerative conditions (hydrocephalus, space-occupying lesions) 4, 7

Additional Testing for Complex Cases

  • Neuropsychological evaluation is recommended when:
    • Patient's presentation is complex or atypical 1, 6
    • Symptoms are mild or unusual 1, 9
    • There are educational, language, or cultural considerations 1, 9
    • Patient has comorbidities that may present as cognitive impairment 1, 6
  • Additional tests based on clinical suspicion (Tier 2):
    • Serology for syphilis or HIV 4, 7
    • Lipid profile 4
    • Inflammatory markers (ESR, CRP) 4, 1
    • HbA1c in suspected diabetes 4

Specialized Testing (Tier 3-4)

  • For early-onset (<65 years) or rapidly progressive dementia:
    • Lumbar puncture with CSF analysis 4, 1
    • Advanced neuroimaging: PET scans with FDG or amyloid PET 4, 1

Detecting Malingering or Factitious Symptoms

  • Look for inconsistencies between observed behaviors and test performance 9
  • Compare self-reported symptoms with informant reports - significant discrepancies may suggest malingering 1
  • Assess for patterns of performance that are inconsistent with known patterns of cognitive impairment in dementia 9
  • Serial/longitudinal assessments can reveal inconsistent patterns over time that don't match expected progression of dementia 9, 1
  • Neuropsychological testing can include specific validity measures to detect effort and motivation issues 1, 9
  • Performance on very simple tasks should not be worse than on more complex tasks within the same cognitive domain 9

Follow-up and Monitoring

  • For patients with subjective cognitive decline but normal testing:
    • Provide reassurance if there is negative corroborative history 1
    • Schedule annual follow-ups if there is positive corroborative history 1
  • Track response to treatment and change over time using the same standardized tools at regular intervals (typically every 6-12 months) 1

Common Pitfalls to Avoid

  • Diagnosis should not be based solely on impaired cognitive screening test results 1, 9
  • Always rule out conditions that mimic dementia, such as depression, metabolic disturbances, medication effects, and sleep disorders 2, 6
  • Standard cognitive screening tests (MMSE, MoCA) may not be sufficient to capture subtle changes in atypical dementia syndromes 1, 9
  • Relying solely on patient self-report without informant input can lead to missed diagnoses 1
  • Failure to consider cultural, educational, and language factors when interpreting cognitive test results 1, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria and Management of Dementia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation of Organic Causes in Dementia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of dementia: 2. Diagnosis.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008

Guideline

Assessment of Frontal Lobe Functions in Geriatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.